The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Multiplex Molecular Diagnostic-Global Market Insights and Sales Trends 2024
Synopsis
Since last few years, research and development of multiplex molecular diagnostics test in clinical microbiology have allowed many laboratories around the world to grow more rapidly and with ease. This has also helped many of these institution to analyze these pathogens directly using multiplex molecular diagnostics in clinical specimens. Above all, recent developments such as approval from USFDA to analyze multiple organisms in single run is helping the market of molecular diagnostic panels to flourish. Using multiplex molecular diagnostics tools, researchers and laboratory personals are able to identify most common laboratory pathogens in gastrointestinal and respiratory more effectively. The w respiratory viral, gastrointestinal, or central nervous system infections.
The global Multiplex Molecular Diagnostic market size is expected to reach US$ 8522.7 million by 2029, growing at a CAGR of 6.9% from 2023 to 2029. The market is mainly driven by the significant applications of Multiplex Molecular Diagnostic in various end use industries. The expanding demands from the Clinical Research Laboratory, Hospitals, Academic and Research Centers and Others, are propelling Multiplex Molecular Diagnostic market. Real-time PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nested PCR with Melt Curve Analysis segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Multiplex Molecular Diagnostic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Multiplex Molecular Diagnostic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Multiplex Molecular Diagnostic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Multiplex Molecular Diagnostic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Multiplex Molecular Diagnostic covered in this report include BD, bioMérieux, SpeeDx, Roche, Contextual Genomics, GenMark Diagnostics, Hologic, Luminex Corporation and Binx Health, etc.
The global Multiplex Molecular Diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
bioMérieux
SpeeDx
Roche
Contextual Genomics
GenMark Diagnostics
Hologic
Luminex Corporation
Binx Health
Global Multiplex Molecular Diagnostic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Multiplex Molecular Diagnostic market, Segment by Type:
Real-time PCR
Nested PCR with Melt Curve Analysis
PCR with Low density Microarray
PCR with Liquid Phase Bead Array
PCR with Electrochemical Detection
Global Multiplex Molecular Diagnostic market, by Application
Clinical Research Laboratory
Hospitals
Academic and Research Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Multiplex Molecular Diagnostic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Since last few years, research and development of multiplex molecular diagnostics test in clinical microbiology have allowed many laboratories around the world to grow more rapidly and with ease. This has also helped many of these institution to analyze these pathogens directly using multiplex molecular diagnostics in clinical specimens. Above all, recent developments such as approval from USFDA to analyze multiple organisms in single run is helping the market of molecular diagnostic panels to flourish. Using multiplex molecular diagnostics tools, researchers and laboratory personals are able to identify most common laboratory pathogens in gastrointestinal and respiratory more effectively. The w respiratory viral, gastrointestinal, or central nervous system infections.
The global Multiplex Molecular Diagnostic market size is expected to reach US$ 8522.7 million by 2029, growing at a CAGR of 6.9% from 2023 to 2029. The market is mainly driven by the significant applications of Multiplex Molecular Diagnostic in various end use industries. The expanding demands from the Clinical Research Laboratory, Hospitals, Academic and Research Centers and Others, are propelling Multiplex Molecular Diagnostic market. Real-time PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nested PCR with Melt Curve Analysis segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Multiplex Molecular Diagnostic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Multiplex Molecular Diagnostic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Multiplex Molecular Diagnostic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Multiplex Molecular Diagnostic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Multiplex Molecular Diagnostic covered in this report include BD, bioMérieux, SpeeDx, Roche, Contextual Genomics, GenMark Diagnostics, Hologic, Luminex Corporation and Binx Health, etc.
The global Multiplex Molecular Diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
bioMérieux
SpeeDx
Roche
Contextual Genomics
GenMark Diagnostics
Hologic
Luminex Corporation
Binx Health
Global Multiplex Molecular Diagnostic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Multiplex Molecular Diagnostic market, Segment by Type:
Real-time PCR
Nested PCR with Melt Curve Analysis
PCR with Low density Microarray
PCR with Liquid Phase Bead Array
PCR with Electrochemical Detection
Global Multiplex Molecular Diagnostic market, by Application
Clinical Research Laboratory
Hospitals
Academic and Research Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Multiplex Molecular Diagnostic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Multiplex Molecular Diagnostic
1.1 Multiplex Molecular Diagnostic Market Overview
1.1.1 Multiplex Molecular Diagnostic Product Scope
1.1.2 Multiplex Molecular Diagnostic Market Status and Outlook
1.2 Global Multiplex Molecular Diagnostic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Multiplex Molecular Diagnostic Market Size by Region (2018-2029)
1.4 Global Multiplex Molecular Diagnostic Historic Market Size by Region (2018-2023)
1.5 Global Multiplex Molecular Diagnostic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Multiplex Molecular Diagnostic Market Size (2018-2029)
1.6.1 North America Multiplex Molecular Diagnostic Market Size (2018-2029)
1.6.2 Europe Multiplex Molecular Diagnostic Market Size (2018-2029)
1.6.3 Asia-Pacific Multiplex Molecular Diagnostic Market Size (2018-2029)
1.6.4 Latin America Multiplex Molecular Diagnostic Market Size (2018-2029)
1.6.5 Middle East & Africa Multiplex Molecular Diagnostic Market Size (2018-2029)
2 Multiplex Molecular Diagnostic Market by Type
2.1 Introduction
2.1.1 Real-time PCR
2.1.2 Nested PCR with Melt Curve Analysis
2.1.3 PCR with Low density Microarray
2.1.4 PCR with Liquid Phase Bead Array
2.1.5 PCR with Electrochemical Detection
2.2 Global Multiplex Molecular Diagnostic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Multiplex Molecular Diagnostic Historic Market Size by Type (2018-2023)
2.2.2 Global Multiplex Molecular Diagnostic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Multiplex Molecular Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Multiplex Molecular Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Multiplex Molecular Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Multiplex Molecular Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Multiplex Molecular Diagnostic Revenue Breakdown by Type (2018-2029)
3 Multiplex Molecular Diagnostic Market Overview by Application
3.1 Introduction
3.1.1 Clinical Research Laboratory
3.1.2 Hospitals
3.1.3 Academic and Research Centers
3.1.4 Others
3.2 Global Multiplex Molecular Diagnostic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Multiplex Molecular Diagnostic Historic Market Size by Application (2018-2023)
3.2.2 Global Multiplex Molecular Diagnostic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Multiplex Molecular Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Multiplex Molecular Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Multiplex Molecular Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Multiplex Molecular Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Multiplex Molecular Diagnostic Revenue Breakdown by Application (2018-2029)
4 Multiplex Molecular Diagnostic Competition Analysis by Players
4.1 Global Multiplex Molecular Diagnostic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Multiplex Molecular Diagnostic as of 2022)
4.3 Date of Key Players Enter into Multiplex Molecular Diagnostic Market
4.4 Global Top Players Multiplex Molecular Diagnostic Headquarters and Area Served
4.5 Key Players Multiplex Molecular Diagnostic Product Solution and Service
4.6 Competitive Status
4.6.1 Multiplex Molecular Diagnostic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BD
5.1.1 BD Profile
5.1.2 BD Main Business
5.1.3 BD Multiplex Molecular Diagnostic Products, Services and Solutions
5.1.4 BD Multiplex Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.1.5 BD Recent Developments
5.2 bioMérieux
5.2.1 bioMérieux Profile
5.2.2 bioMérieux Main Business
5.2.3 bioMérieux Multiplex Molecular Diagnostic Products, Services and Solutions
5.2.4 bioMérieux Multiplex Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.2.5 bioMérieux Recent Developments
5.3 SpeeDx
5.3.1 SpeeDx Profile
5.3.2 SpeeDx Main Business
5.3.3 SpeeDx Multiplex Molecular Diagnostic Products, Services and Solutions
5.3.4 SpeeDx Multiplex Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Multiplex Molecular Diagnostic Products, Services and Solutions
5.4.4 Roche Multiplex Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 Contextual Genomics
5.5.1 Contextual Genomics Profile
5.5.2 Contextual Genomics Main Business
5.5.3 Contextual Genomics Multiplex Molecular Diagnostic Products, Services and Solutions
5.5.4 Contextual Genomics Multiplex Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.5.5 Contextual Genomics Recent Developments
5.6 GenMark Diagnostics
5.6.1 GenMark Diagnostics Profile
5.6.2 GenMark Diagnostics Main Business
5.6.3 GenMark Diagnostics Multiplex Molecular Diagnostic Products, Services and Solutions
5.6.4 GenMark Diagnostics Multiplex Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.6.5 GenMark Diagnostics Recent Developments
5.7 Hologic
5.7.1 Hologic Profile
5.7.2 Hologic Main Business
5.7.3 Hologic Multiplex Molecular Diagnostic Products, Services and Solutions
5.7.4 Hologic Multiplex Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.7.5 Hologic Recent Developments
5.8 Luminex Corporation
5.8.1 Luminex Corporation Profile
5.8.2 Luminex Corporation Main Business
5.8.3 Luminex Corporation Multiplex Molecular Diagnostic Products, Services and Solutions
5.8.4 Luminex Corporation Multiplex Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.8.5 Luminex Corporation Recent Developments
5.9 Binx Health
5.9.1 Binx Health Profile
5.9.2 Binx Health Main Business
5.9.3 Binx Health Multiplex Molecular Diagnostic Products, Services and Solutions
5.9.4 Binx Health Multiplex Molecular Diagnostic Revenue (US$ Million) & (2018-2023)
5.9.5 Binx Health Recent Developments
6 North America
6.1 North America Multiplex Molecular Diagnostic Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Multiplex Molecular Diagnostic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Multiplex Molecular Diagnostic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Multiplex Molecular Diagnostic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Multiplex Molecular Diagnostic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Multiplex Molecular Diagnostic Market Dynamics
11.1 Multiplex Molecular Diagnostic Industry Trends
11.2 Multiplex Molecular Diagnostic Market Drivers
11.3 Multiplex Molecular Diagnostic Market Challenges
11.4 Multiplex Molecular Diagnostic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
